| 6802 | A | 062981 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN V POTASSIUM | DAVA PHARMS INC | EQ 250MG BASE/5ML | | [] | 1989-02-10 | Feb 10, 1989 | No | No | No | DISCN | DAVA PHARMACEUTICALS INC | 3a0802b0e7897f21ba3f6488c1bae70c50e145528ae4804f43ad7fa937831f0e |
| 6803 | A | 061624 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN V POTASSIUM | MYLAN | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 35495bc0c19471f41d67d87902dc5166c186a27d9a0662afc98ad8efddd00ffc |
| 6804 | A | 061624 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN V POTASSIUM | MYLAN | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | MYLAN PHARMACEUTICALS INC | f4ad17805a9ae4c52cc27b557fbcd849f737b15bcff5a704b81bbb1ad2a054cb |
| 6805 | A | 061758 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN V POTASSIUM | PUREPAC PHARM | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PUREPAC PHARMACEUTICAL CO | ce9a9782e6c8db3c3dc9e9a297463c7745de24a87b2f7af19cddebdb8453d6b6 |
| 6806 | A | 061758 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN V POTASSIUM | PUREPAC PHARM | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PUREPAC PHARMACEUTICAL CO | f917fde25503ba737b789d99a21469bfff4a30101c2657a2c849564cd26caf6d |
| 6807 | A | 060307 | 003 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN-2 | TEVA | 250,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | 0d982c40e093910e5992ec1086c2cee9a67e367386db2c7eb81e51fc322d4acb |
| 6808 | A | 060456 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN-VK | TEVA | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | RX | TEVA PHARMACEUTICALS USA INC | 23b2fa263f3dcab7e1bd51e4d6b9d8b93bfd8212b57dae5823e637ed4d5e79c1 |
| 6809 | A | 060456 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN-VK | TEVA | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | Yes | RX | TEVA PHARMACEUTICALS USA INC | 0a079f6302165c14e003f503f54fb86f53d9e4aa1b4ba003bed545fb8ba2062c |
| 6810 | A | 062149 | 001 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENTIDS '200' | APOTHECON | 200,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON SUB BRISTOL MYERS SQUIBB CO | 831f56f24a69fdee69b0c7b031a11c634bf8e0f57e4481e8f75f160cdb06b3cd |
| 6811 | A | 062149 | 002 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENTIDS '400' | APOTHECON | 400,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON SUB BRISTOL MYERS SQUIBB CO | 1a52f3be3ee802d26ba7bab7109cacf7495803ec4620071a0a0a4411278d7cea |
| 6812 | A | 060587 | 001 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PFIZERPEN G | PFIZER | 400,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PFIZER LABORATORIES DIV PFIZER INC | 64ac498eab5f7291a6def3d0dfe55323f2c40a0fbdd751801774c556900da960 |
| 6813 | A | 061815 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PFIZERPEN VK | PFIZER | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PFIZER LABORATORIES DIV PFIZER INC | 265f35c6caa5bd11ec4a979c72445f6e2d5be88d06f5a52ef2248ef9c0ddebec |
| 6814 | A | 061815 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PFIZERPEN VK | PFIZER | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PFIZER LABORATORIES DIV PFIZER INC | 757a8d445596051589b789df5dd5a38e6986ed5869bbab078ab18714860e1cee |
| 6815 | N | 211281 | 001 | LACTITOL | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PIZENSY | BRAINTREE LABS | 10GM | | [] | 2020-02-12 | Feb 12, 2020 | No | Yes | No | DISCN | BRAINTREE LABORATORIES INC | c9ed3eeb5fbea2a869624bb11c204637ec62f145d913c7cd16d8cc85cf240b58 |
| 6816 | N | 209381 | 001 | ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PLENVU | SALIX | 7.54GM;140GM;2.2GM;48.11GM;5.2GM;9GM | | [] | 2018-05-04 | May 4, 2018 | No | Yes | Yes | RX | SALIX PHARMACEUTICALS INC | 88c01fca2bd53e5cc5c8038e067f61b611fe7ece459cc81b2d6541f08f727870 |
| 6817 | A | 202850 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | ANI PHARMS INC | 17GM/SCOOPFUL | | [] | 2015-12-15 | Dec 15, 2015 | No | No | No | OTC | ANI PHARMACEUTICALS INC | 9edc9b02b42b0431d8864ad9d6ad24027349fdbb4c3c536bdaab7ae9ab15195f |
| 6818 | A | 209017 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | AUROBINDO PHARMA LTD | 17GM/SCOOPFUL | | [] | 2018-04-09 | Apr 9, 2018 | No | No | No | OTC | AUROBINDO PHARMA LTD | 6f31f73e84af244a038ccad620ed6725542dabc0c557f9cf22ae39ab070ab89e |
| 6819 | A | 077736 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | BRECKENRIDGE PHARM | 17GM/SCOOPFUL | | [] | 2006-05-26 | May 26, 2006 | No | No | No | DISCN | BRECKENRIDGE PHARMACEUTICAL INC | 0b9588ce54da74eeca9449d44647f146dc5a29e1a25db6b551994a23c082a889 |
| 6820 | A | 090812 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | LGM PHARMA | 17GM/SCOOPFUL | | [] | 2009-10-07 | Oct 7, 2009 | No | No | No | OTC | LGM PHARMA SOLUTIONS LLC | 7d30505e79abbcbae727a56fc1f658cf7efdd22b705366356bf0fe1d5a00115c |
| 6821 | A | 078915 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | MYLAN | 17GM/PACKET | | [] | 2009-10-06 | Oct 6, 2009 | No | No | No | OTC | MYLAN PHARMACEUTICALS INC | 1686c592a98d438548499a46b2d811c936aa0f515d05cce978019e179798cc1d |
| 6822 | A | 078915 | 002 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | MYLAN | 17GM/SCOOPFUL | | [] | 2009-10-06 | Oct 6, 2009 | No | No | No | OTC | MYLAN PHARMACEUTICALS INC | 5288dace84a7ea214de304672bdd697485abc1722f6d98df028818231687a31a |
| 6823 | A | 077706 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | NEXGEN PHARMA INC | 17GM/SCOOPFUL | | [] | 2006-09-27 | Sep 27, 2006 | No | No | No | DISCN | NEXGEN PHARMA INC | bb683ed645b7016c016c6e30b354b3a7fad0264f914b6f76313ee865db858c3f |
| 6824 | A | 091077 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | NOVEL LABS INC | 17GM/SCOOPFUL | | [] | 2009-10-06 | Oct 6, 2009 | No | No | No | OTC | NOVEL LABORATORIES INC | 173f08aaa67a93aa492152ee2d01514ad4375929b205d0cb7903102df166b98f |
| 6825 | A | 202071 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | NOVELGENIX THERAPS | 17GM/SCOOPFUL | | [] | 2012-12-28 | Dec 28, 2012 | No | No | No | OTC | NOVELGENIX THERAPEUTICS PVT LTD | 0086bcfa27fefeede5313b0c08041619acca4869e6d96d56557983b51a2e66d0 |
| 6826 | A | 206105 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | NUVO PHARMS INC | 17GM/SCOOPFUL | | [] | 2016-10-28 | Oct 28, 2016 | No | No | No | OTC | NUVO PHAMACEUTICALS INC | 437e2145e0b20f24bfe9c0bb0064635667b9b765a8578ce274c4609b744e9a9b |
| 6827 | A | 077893 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | PADDOCK LLC | 17GM/SCOOPFUL | | [] | 2006-05-26 | May 26, 2006 | No | No | No | DISCN | PADDOCK LABORATORIES LLC | 9bdd05617c9767089ab08f3884c65438c644c622f998d567c96acaa750861973 |
| 6828 | A | 090567 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | PADDOCK LLC | 17GM/SCOOPFUL | | [] | 2009-10-15 | Oct 15, 2009 | No | No | No | DISCN | PADDOCK LABORATORIES LLC | 9307a857e12caa47cfe1eb30842f6383d00040a78cf06fd550b05805090838f6 |
| 6829 | A | 079214 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | PAR PHARM | 17GM/SCOOPFUL | | [] | 2013-01-31 | Jan 31, 2013 | No | No | No | OTC | PAR PHARMACEUTICAL INC | b75df128bb1495a8f87dd679815eae530a62fc5fef830bf15036fc1688c1f0f3 |
| 6830 | A | 090685 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | PERRIGO R AND D | 17GM/PACKET | | [] | 2009-10-06 | Oct 6, 2009 | No | No | No | OTC | PERRIGO R AND D CO | 84eaad3f80591843f20176110c70b69efba59bad13460630b0bfaabcf6a3434a |
| 6831 | A | 090685 | 002 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | PERRIGO R AND D | 17GM/SCOOPFUL | | [] | 2009-10-06 | Oct 6, 2009 | No | No | No | OTC | PERRIGO R AND D CO | 3f6e7457dcff270eb65c6238e3dbc9ea1343fabc82656229612ff5a43f97a1ac |
| 6832 | A | 203928 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | STRIDES PHARMA | 17GM/SCOOPFUL | | [] | 2016-08-24 | Aug 24, 2016 | No | No | No | OTC | STRIDES PHARMA GLOBAL PTE LTD | 0ae4a6f4bf5c1965ba733d6bce745db2a76204676427650e49ad460c91c5f6cb |
| 6833 | A | 203928 | 002 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | STRIDES PHARMA | 17GM/PACKET | | [] | 2016-08-24 | Aug 24, 2016 | No | No | No | OTC | STRIDES PHARMA GLOBAL PTE LTD | 8898fa9f284214b3994d528e70d6b092a67acd40d431c0d4f9efb2568eea941d |
| 6834 | A | 077445 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 | TEVA PHARMS | 17GM/SCOOPFUL | | [] | 2006-05-04 | May 4, 2006 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA | 12dc94d6028f960097ebe652eb04e3fbbc751052aef67fa24d601f61105a9b0c |
| 6835 | A | 090712 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES | PADDOCK LLC | 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/BOT;22.72GM/BOT | | [] | 2010-02-25 | Feb 25, 2010 | No | No | No | DISCN | PADDOCK LABORATORIES LLC | 83de5bbee9d0913c14d59e3d2b87fbec203330b63ed51ed6031c8d283da52167 |
| 6836 | A | 204558 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES | STRIDES PHARMA | 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT | AA | ["AA"] | 2018-12-21 | Dec 21, 2018 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 25bf2fc5d9c7b1a6c1f2f55fbca8375825651a1e758a4c303f9ede320e8400b7 |
| 6837 | A | 210902 | 001 | POTASSIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POTASSIUM CHLORIDE | AMNEAL | 20MEQ | AA | ["AA"] | 2019-05-23 | May 23, 2019 | No | No | No | RX | AMNEAL PHARMACEUTICALS LLC | b9ef4344a0aa4eedbfdf54e1f5e7fb38a0104f08d068597c9317bdf858e9b181 |
| 6838 | A | 212183 | 001 | POTASSIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POTASSIUM CHLORIDE | BELCHER | 20MEQ | AA | ["AA"] | 2019-05-06 | May 6, 2019 | No | No | No | RX | BELCHER PHARMACEUTICALS LLC | c2e290006bd8d2edd62fffd422a6db45d6014b0bf8c204416b6e39d5fd7d1fb4 |
| 6839 | A | 210200 | 001 | POTASSIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POTASSIUM CHLORIDE | EPIC PHARMA LLC | 20MEQ | AA | ["AA"] | 2018-11-23 | Nov 23, 2018 | No | No | No | RX | EPIC PHARMA LLC | e61c97dba78e12d4ef1feee0e474f7f5c583c992fb198ac6cfe67c95251e83f5 |
| 6840 | A | 210241 | 001 | POTASSIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POTASSIUM CHLORIDE | NOVEL LABS INC | 20MEQ | AA | ["AA"] | 2018-11-21 | Nov 21, 2018 | No | No | No | RX | NOVEL LABORATORIES INC | 441d06b3a0595c2d981a764684dce980b8f4b59556dc23ae3bdbfd3b4fb908da |
| 6841 | N | 208019 | 001 | POTASSIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POTASSIUM CHLORIDE | PHARMA RES SOFTWARE | 20MEQ | AA | ["AA"] | 2015-08-19 | Aug 19, 2015 | No | Yes | Yes | RX | PHARMA RESEARCH SOFTWARE SOLUTION LLC | 04fff2205b4316e08217925f1507aca74bf03ef88fd3de4aa8c27a72f345325e |
| 6842 | A | 211667 | 001 | POTASSIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POTASSIUM CHLORIDE | STRIDES PHARMA | 20MEQ | AA | ["AA"] | 2021-03-11 | Mar 11, 2021 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | e04374d79d5ef5ea12ef18ac4f154c9bf8649b3c882e71ecb242dcc0a9d79661 |
| 6843 | N | 019647 | 002 | POTASSIUM CITRATE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POTASSIUM CITRATE | UT SW MEDCTR | 10MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1988-10-13 | Oct 13, 1988 | No | Yes | No | DISCN | UT SOUTHWESTERN MEDCTR | e3d68f85db854d0f72a9e7ac781b45a4a9e2e3667a62840bd9119f41a42a4865 |
| 6844 | N | 019647 | 001 | POTASSIUM CITRATE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | POTASSIUM CITRATE | UT SW MEDCTR | 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1988-10-13 | Oct 13, 1988 | No | Yes | No | DISCN | UT SOUTHWESTERN MEDCTR | dfa661ce50f5378fe32f32b2754533d8bbab77477466f461f13c485ed02cb1b7 |
| 6845 | N | 202535 | 001 | CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PREPOPIK | FERRING PHARMS INC | 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 2012-07-16 | Jul 16, 2012 | No | Yes | No | DISCN | FERRING PHARMACEUTICALS INC | 90947c1411fc7313b3e3e1870294bcec8ec212db002934c960096688847df146 |
| 6846 | N | 050194 | 001 | OXACILLIN SODIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PROSTAPHLIN | APOTHECON | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 2d5baa13ab37fa911eff030e5420a1344738be0efca2ecb67a49df2c37a8ae2c |
| 6847 | N | 020900 | 001 | UREA C-13 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PYLORI-CHEK BREATH TEST | DXS DEVICES | 100MG/VIAL | | [] | 1999-02-04 | Feb 4, 1999 | No | No | No | DISCN | DIAGNOSTICS AND DEVICES INC | 29964acd591e109e91544ec5d6d4506ee7480b138587750757765a0cdaa64e04 |
| 6848 | N | 022006 | 001 | VIGABATRIN | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | SABRIL | LUNDBECK PHARMS LLC | 500MG/PACKET | AA | ["AA"] | 2009-08-21 | Aug 21, 2009 | No | Yes | Yes | RX | LUNDBECK PHARMACEUTICALS LLC | e91e88aff9b503b52e1d5cba8217166e4e220569eef5d80515a6ddf9e7460c92 |
| 6849 | A | 077774 | 001 | STAVUDINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | STAVUDINE | AUROBINDO PHARMA | 1MG/ML | | [] | 2008-12-29 | Dec 29, 2008 | No | No | No | DISCN | AUROBINDO PHARMA LTD | eef897d4df2587428e498da8dc6a18a12dd7b947342989c5978e21133106ab84 |
| 6850 | A | 078030 | 001 | STAVUDINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | STAVUDINE | CIPLA LTD | 1MG/ML | | [] | 2009-03-20 | Mar 20, 2009 | No | No | No | DISCN | CIPLA LTD | 99a02353aab1eb4f227877418d4e70be294593b2c918673d3c4805f8ea74f139 |
| 6851 | A | 061453 | 001 | CLOXACILLIN SODIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | TEGOPEN | APOTHECON | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | fc086b2bb4ab0221c2455862f991510aa4fe76e1a7a1d3201a2bf6d7df440f95 |